Search Results
Jul 22, 2026, 08:31 ET LightPath Technologies Receives $13 Million in Follow-On Optical Assembly Orders from Leading C-UAS & Defense Systems Supplier
those factors detailed by the Company in its public filings with the Securities and Exchange Commission (the "SEC"), including its Annual Report on Form 10-K and other filings with the SEC. Should one or more of these risks, uncertainties, or facts materialize, or should underlying assumptions prove
More news about: LightPath Technologies
Jul 22, 2026, 08:31 ET SKNV Announces Exclusive Commercialization Rights to Washington University Patent Portfolio Covering Combination of Fluorouracil and Calcipotriene Therapies
increases with age.1-3Left untreated, actinic keratosis (AK) can progress to squamous cell carcinoma (SCC), the second most common form of skin cancer. The incidence of SCC has increased substantially in recent decades, with some studies reporting increases of up to 200%.5In
More news about: SKNV
Jul 22, 2026, 08:30 ET NeuroSense Advances PrimeC Toward New Drug Submission to Health Canada for ALS
The meeting also included an expert clinical perspective from a leading Canadian ALS specialist, as well as additional supportive analyses that will form part of the planned NDS package, further strengthening the growing body of evidence supporting PrimeC's potential in ALS."This marks an important
More news about: NeuroSense
Jul 22, 2026, 08:30 ET Perrigo to Release Second Quarter 2026 Financial Results on August 5, 2026
and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025.Perrigo ContactsEric Jacobson, Vice President, Global Investor Relations(616)
More news about: Perrigo Company plc
Jul 22, 2026, 08:30 ET NTH CYCLE INC., A PURE PLAY CRITICAL MINERAL REFINING COMPANY, TO LIST ON NYSE THROUGH BUSINESS COMBINATION WITH KENSINGTON CAPITAL ACQUISITION CORP. VI
the proposed transaction, including a copy of the Business Combination Agreement and investor presentation, will be provided in a Current Report on Form 8-K to be filed by Kensington with the U.S. Securities and Exchange Commission (the "SEC") and available at www.sec.gov.AdvisorsHughes
More news about: Kensington Capital Acquisition Corp. VI
Jul 22, 2026, 08:00 ET Kessler Topaz Meltzer & Check, LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of CytoDyn Inc. common stock
www.CytoDynSecuritiesSettlement.com, no later than September 21, 2026, in accordance with the instructions set forth in the Claim Form. If you are a Settlement Class Member and do not submit a proper Claim Form, you will not be eligible to share in the distribution of the net proceeds of the Settlement, but you will nevertheless
More news about: Kessler Topaz Meltzer & Check, LLP
Jul 22, 2026, 08:00 ET Element Advances Intelligent Mobility with DigiAdvisor, a New AI-Powered Decisioning Tool
Management Discussion and Analysis for the twelve-month period ended December 31, 2025, and under the heading "Risk Factors" in Element's Annual Information Form for the year ended December 31, 2025, which have been filed on SEDAR+ and can be accessed on Element's profile on
More news about: Element Fleet Management Inc.
Jul 22, 2026, 08:00 ET Crystalys Therapeutics Announces $130 Million Series B Financing to Advance Global Phase 3 Development and Commercialization of Dotinurad for Gout
impact for patients and also believe in the company's ability to work towards commercialization."About Gout Gout is the most common form of inflammatory arthritis. It is a condition that is very debilitating for patients and characterized by sudden, severe attacks of pain, swelling, redness
More news about: Crystalys Therapeutics
Jul 22, 2026, 08:00 ET Dario Announces Pricing of a $23.5 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
sole placement agent for the offering.The securities described above are being offered pursuant to an effective shelf registration statement on Form S-3 (File No. 333-294454) which became effective on March 27, 2026. The Offering is being made only by means of a prospectus which is part of the effective
More news about: DarioHealth Corp.
Jul 22, 2026, 08:00 ET Kirin Group and Blackmores to Launch New Cognizin® Cognitive Support Supplements in Australia and New Zealand
society.About Cognizin® CiticolineCognizin® Citicoline, crafted by Kyowa Hakko Bio Co., Ltd., is a clinically validated, patented form of Citicoline, a vital nutrient for brain vitality. Rooted in over 75 years of biotech innovation and Kirin Holdings' century-long fermentation expertise,
More news about: Kyowa Hakko U.S.A
Jul 22, 2026, 07:45 ET Ukraine Ministry of Health Accepts Entolimod Dossier for Formal Review Under Regulatory Equivalence Pathway
risks and uncertainties relevant to the company, and other important factors, see Valion Bio's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 30, 2026, under the heading "Risk Factors," as well as the company's subsequent
More news about: Valion Bio, Inc.
Jul 22, 2026, 07:40 ET TuHURA Biosciences to Present at Canaccord Genuity's 46th Annual Growth Conference
regarding the timing and likelihood of regulatory approvals; and the other risks described from time to time in detail in Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed on March 31, 2026, and TuHURA's other reports and filings with the SEC from time to time,
More news about: TuHURA Biosciences, Inc.
Jul 22, 2026, 07:30 ET Baidu Provides Update on Voluntary Conversion to Dual-Primary Listing on The Main Board of The Stock Exchange of Hong Kong Limited
accordance with applicable laws and regulations as and when appropriate. This announcement is for information purposes only and does not constitute, or form part of, any invitation or offer to acquire, purchase or subscribe for any securities of the Company. Shareholders and potential investors should exercise
More news about: Baidu, Inc.
Jul 22, 2026, 07:30 ET Auxly Announces 14:1 Share Consolidation
be rounded down to the nearest whole number of Common Shares.The Company's registered shareholders holding their Common Shares in certificated form will receive a letter of transmittal from Computershare Investor Services Inc. ("Computershare"), the Company's transfer agent, in respect to
More news about: Auxly Cannabis Group Inc.
Jul 22, 2026, 07:29 ET Eve Air Mobility and FDOT Partner to Advance Advanced Air Mobility in Florida
Operations of the company's most recent Annual Report on Form 10-K, Part I, Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations and Part II, Item 1A. Risk Factors of the company's most recent Quarterly Report on Form 10-Q, and other risks and uncertainties listed from
More news about: Eve Air Mobility
Jul 22, 2026, 07:07 ET Garmin acquires TrainingPeaks and TrainHeroic, leading endurance and strength training platforms for athletes and coaches
including, but not limited to, the risk factors listed in the Annual Report on Form 10-K for the year ended December 27, 2025, filed by Garmin with the Securities and Exchange Commission (Commission file number 0-31983). Copies of such Form 10-K are available at
More news about: Garmin Ltd.
Jul 22, 2026, 07:03 ET Tikva Allocell Closes $8 Million Series A Financing to Advance Engineered EBV-Specific T-Cell Therapy for Solid Tumors
further enhanced through Tikva's proprietary protein‑engineering strategies. These cells are equipped with a B7‑H3–targeting receptor and an optimized form of SerpinB9, a natural inhibitor of granzyme B, the enzyme immune cells use to kill their targets. Because a patient's immune system would normally
More news about: Tikva Allocell
Jul 22, 2026, 07:01 ET Iridium Announces Second Quarter 2026 Results
include those factors listed under the caption "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission ("SEC") on February 12, 2026, and the Company's Form 10-Q for the quarter ended June 30, 2026, filed with the SEC on July 22, 2026,
More news about: Iridium Communications Inc.
Jul 22, 2026, 07:00 ET Mentari Therapeutics Announces $200 Million Private Placement for Migraine Prevention Pipeline
registration statement on Form S-4 that includes a preliminary proxy statement/prospectus of InMed and a management information circular and will file other relevant documents with the SEC and applicable Canadian securities regulators. The Form S-4 has not yet become effective. After the Form S-4 is declared effective,
More news about: Mentari Therapeutics
Jul 22, 2026, 07:00 ET TopGum Advances Longevity with Gummies for Cognition and Vision
of cordyceps, reishi, lion's mane, turkey tail, and six other varieties; a B12 gummy with 1000mcg of methylcobalamin—the highly bioavailable, active form of vitamin vital for nerve health and function. The gummies can be custom designed to meet desired flavors, shapes, colors, and formulations.The
More news about: TopGum Industries, Inc.
Jul 22, 2026, 07:00 ET Graphite One Highlights Strategic Alignment with White House Executive Order Reinforcing U.S. Critical Minerals Supply Chain
economic competitiveness and national security.Graphite One's complete domestic supply chain strategy has received U.S. government support in the form of two Department of War grants – under Defense Production Act authority and from the Defense Logistics Agency – is listed on the Federal Fast-41 permitting
More news about: Graphite One Inc.
Jul 22, 2026, 07:00 ET Sharon AI Appoints Anuj Goel as Chief Financial Officer
forward-looking statements include, among others, all of the risks described in the "Risk Factors" section of the Company's most recent Annual Report on Form 10-K filed with the SEC and other reports subsequently filed with the SEC. Additional assumptions, risks and uncertainties are described in detail in
More news about: SharonAI Holdings Inc.
Jul 22, 2026, 07:00 ET OceanaGold Announces Renewal of Share Buyback
risk factors identified and described in more detail in the section entitled "Risk Factors" contained in the Company's most recent Annual Information Form and the Company's other filings with Canadian securities regulators and the U.S. Securities and Exchange Commission (the "SEC"), which are available
More news about: OceanaGold Corporation
Jul 22, 2026, 07:00 ET OceanaGold Announces Renewal of Share Buyback
risk factors identified and described in more detail in the section entitled "Risk Factors" contained in the Company's most recent Annual Information Form and the Company's other filings with Canadian securities regulators and the U.S. Securities and Exchange Commission (the "SEC"), which are available
More news about: OceanaGold Corporation
Jul 22, 2026, 07:00 ET Curis Announces Positive Emavusertib Update
indicated by forward-looking statements include the factors set forth under the captions "Risk Factor Summary" and "Risk Factors" in our most recent Form 10-K, and the factors that are discussed in other filings that Curis periodically makes with the Securities and Exchange Commission. In addition, any
More news about: Curis, Inc.